Pacific Biosciences of California (MEX:PACB) E10: MXN-23.33 (As of Mar. 2026)


MEX:PACB Pacific Biosciences of California Inc MEX:PACB
53 GF Score
Price MXN27.50
GF Value MXN27.00
! 8 Warning Signs
View Full Analysis

What is Pacific Biosciences of California E10?

Pacific Biosciences of California MEX:PACB 53 E10 is MXN-23.33 as of Mar. 2026. GuruFocus rates MEX:PACB with a GF Score™ of 53/100 and a GF Value™ of MXN27.00. The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pacific Biosciences of California's adjusted earnings per share data for the three months ended in Mar. 2026 was MXN-0.541. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN-23.33 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was -6.70% per year. During the past 5 years, the average E10 Growth Rate was -1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Pacific Biosciences of California was 62.50% per year. The lowest was -6.70% per year. And the median was 1.30% per year.

As of today (2026-06-30), Pacific Biosciences of California's current stock price is MXN27.50. Pacific Biosciences of California's E10 for the quarter that ended in Mar. 2026 was MXN-23.33. Pacific Biosciences of California's Shiller PE Ratio of today is .


Pacific Biosciences of California  (MEX:PACB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pacific Biosciences of California E10 Related Terms


Pacific Biosciences of California E10 Historical Data

* Premium members only.

The historical data trend for Pacific Biosciences of California's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacific Biosciences of California E10 Chart

Pacific Biosciences of California Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -16.91

Pacific Biosciences of California Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -19.71 -19.44 -16.91 -23.33

MEX:PACB vs KIDS, MOBI, SI: E10 Comparison

For the Medical Devices subindustry, Pacific Biosciences of California's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Biosciences of California Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pacific Biosciences of California's Shiller PE Ratio falls into.


MEX:PACB
53GF Score
Pacific Biosciences of California Inc MEX:PACB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pacific Biosciences of California E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pacific Biosciences of California's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.541/330.2130*330.2130
=-0.541

Current CPI (Mar. 2026) = 330.2130.

Pacific Biosciences of California Quarterly Data

per share eps CPI Adj_EPS
201606 -3.884 241.018 -5.321
201609 -3.674 241.428 -5.025
201612 -4.123 241.432 -5.639
201703 -4.896 243.801 -6.631
201706 -4.700 244.955 -6.336
201709 -3.448 246.819 -4.613
201712 -3.535 246.524 -4.735
201803 -3.634 249.554 -4.809
201806 -3.340 251.989 -4.377
201809 -3.554 252.439 -4.649
201812 -4.123 251.233 -5.419
201903 -3.888 254.202 -5.051
201906 -3.073 256.143 -3.962
201909 -3.751 256.759 -4.824
201912 -0.011 256.974 -0.014
202003 0.234 258.115 0.299
202006 -3.462 257.797 -4.434
202009 -3.093 260.280 -3.924
202012 7.360 260.474 9.331
202103 -9.198 264.877 -11.467
202106 -4.180 271.696 -5.080
202109 1.645 274.310 1.980
202112 -6.359 278.802 -7.532
202203 -7.367 287.504 -8.461
202206 -6.438 296.311 -7.175
202209 -6.839 296.808 -7.609
202212 -7.214 296.797 -8.026
202303 -6.489 301.836 -7.099
202306 -4.800 305.109 -5.195
202309 -4.529 307.789 -4.859
202312 -5.262 306.746 -5.665
202403 -4.813 312.332 -5.089
202406 -11.725 314.175 -12.324
202409 -4.332 315.301 -4.537
202412 -10.219 315.605 -10.692
202503 -29.460 319.799 -30.419
202506 -2.636 322.561 -2.699
202509 -2.385 324.800 -2.425
202512 -2.341 324.054 -2.385
202603 -0.541 330.213 -0.541

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN-23.33 mean?
Pacific Biosciences of California (MEX:PACB) has a E10 of MXN-23.33 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pacific Biosciences of California and its competitors.
Is Pacific Biosciences of California's E10 too high?
Pacific Biosciences of California's current E10 is MXN-23.33. Overall, Pacific Biosciences of California has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Pacific Biosciences of California's E10 compare to KIDS and MOBI?
Pacific Biosciences of California's E10 of MXN-23.33 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pacific Biosciences of California and its competitors. Pacific Biosciences of California's current E10 is MXN-23.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Biosciences of California stock overvalued right now?
Pacific Biosciences of California (MEX:PACB) has a current E10 of MXN-23.33. The stock's GF Value™ is MXN27.00, compared to a current price of MXN27.50 — trading 1.9% above its estimated fair value. The current E10 is MXN-23.33. Pacific Biosciences of California's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Pacific Biosciences of California (MEX:PACB), the current E10 is MXN-23.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pacific Biosciences of California (MEX:PACB) Overvalued in 2026?

Based on GuruFocus' analysis, Pacific Biosciences of California stock appears to be overvalued. The current stock price of MXN27.50 is trading 1.9% above its estimated GF Value™ of MXN27.00.

Key valuation signals for MEX:PACB:

  • E10: MXN-23.33
  • GF Value™: MXN27.00 vs. price of MXN27.50 (1.9% above fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the MEX:PACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pacific Biosciences of California Business Description

Other Exchanges PACB:USAP09:Germany
Address 1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
53GF Score

Get the complete analysis for MEX:PACB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN27.50
Price
MXN27.00
GF Value